Literature DB >> 10100542

The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution.

J I Tokars1, S Satake, D Rimland, L Carson, E R Miller, E Killum, R L Sinkowitz-Cochran, M J Arduino, F C Tenover, B Marston, W R Jarvis.   

Abstract

OBJECTIVE: To study vancomycin-resistant Enterococcus (VRE) prevalence, risk factors, and clustering among hospital inpatients.
DESIGN: Rectal-swab prevalence culture survey conducted from February 5 to March 22, 1996.
SETTING: The Veterans' Affairs Medical Center, Atlanta, Georgia. PATIENTS: Hospital (medical and surgical) inpatients.
RESULTS: The overall VRE prevalence was 29% (42/147 patients). The VRE prevalence was 52% (38/73 patients) among patients who had received at least one of six specific antimicrobials during the preceding 120 days, compared with only 5% (4/74) among those who had not received the antimicrobials (relative risk, 9.6; P<.001). The longer the period (up to 120 days) during which antimicrobial use was studied, the more closely VRE status was predicted. Among 67 hospital patients in 28 multibed rooms, clustering of VRE among current roommates was not found.
CONCLUSIONS: At this hospital with relatively high VRE prevalence, VRE colonization was related to antibiotic use but not to roommate VRE status. In hospitals with a similar VRE epidemiology, obtaining cultures from roommates of VRE-positive patients may not be as efficient a strategy for identifying VRE-colonized patients as obtaining screening cultures from patients who have received antimicrobials.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10100542     DOI: 10.1086/501606

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  11 in total

Review 1.  Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Authors:  Stephan Harbarth; Sara Cosgrove; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Limitations of vitek GPS-418 cards in exact detection of vancomycin-resistant enterococci with the vanB genotype.

Authors:  T Okabe; K Oana; Y Kawakami; M Yamaguchi; Y Takahashi; Y Okimura; T Honda; T Katsuyama
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 3.  Relationships between enterococcal virulence and antimicrobial resistance.

Authors:  L M Mundy; D F Sahm; M Gilmore
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

4.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

5.  Vancomycin-resistant enterococci in Canada revisited.

Authors:  B L Johnston; J M Conly
Journal:  Can J Infect Dis       Date:  2000-05

6.  Incidence and risk factors of infection caused by vancomycin-resistant enterococcus colonization in neurosurgical intensive care unit patients.

Authors:  Young-Bem Se; Hyoung-Joon Chun; Hyeong-Joong Yi; Dong-Won Kim; Yong Ko; Suck-Jun Oh
Journal:  J Korean Neurosurg Soc       Date:  2009-08-31

7.  Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures.

Authors:  Alexander A Padiglione; Rory Wolfe; Elizabeth A Grabsch; Di Olden; Stephen Pearson; Clare Franklin; Denis Spelman; Barrie Mayall; Paul D R Johnson; M Lindsay Grayson
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Gastrointestinal Carriage of Vancomycin-Resistant Enterococci and Carbapenem-Resistant Gram-Negative Bacteria in an Endemic Setting: Prevalence, Risk Factors, and Outcomes.

Authors:  Alexandra Vasilakopoulou; Polyxeni Karakosta; Sophia Vourli; Aikaterini Tarpatzi; Paraskevi Varda; Maria Kostoula; Anastasia Antoniadou; Spyros Pournaras
Journal:  Front Public Health       Date:  2020-03-18

Review 9.  Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance.

Authors:  L R Peterson
Journal:  Clin Microbiol Infect       Date:  2005-10       Impact factor: 8.067

10.  Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005.

Authors:  Marya D Zilberberg; Andrew F Shorr; Marin H Kollef
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.